000			01961 a2200529 4500
005			20250516080507.0
264		0	_c20120629
008			201206s 0 0 eng d
022			_a1530-6860
024	7		_a10.1096/fj.11-195016 _2doi
040			_aNLM _beng _cNLM
100	1		_aJohnston, Tom H
245	0	0	_aA novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates. _h[electronic resource]
260			_bFASEB journal : official publication of the Federation of American Societies for Experimental Biology _cMay 2012
300			_a2154-63 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntiparkinson Agents _xtherapeutic use
650	0	4	_aBenzodioxoles _xtherapeutic use
650	0	4	_aCell Line, Tumor
650	0	4	_aDrug Synergism
650	0	4	_aLevodopa _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMethylamines _xtherapeutic use
650	0	4	_aN-Methyl-3,4-methylenedioxyamphetamine _xanalogs & derivatives
650	0	4	_aParkinson Disease _xdrug therapy
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
700	1		_aMillar, Zak
700	1		_aHuot, Philippe
700	1		_aWagg, Keith
700	1		_aThiele, Sherri
700	1		_aSalomonczyk, Danielle
700	1		_aYong-Kee, Christopher J
700	1		_aGandy, Michael N
700	1		_aMcIldowie, Matthew
700	1		_aLewis, Katie D
700	1		_aGomez-Ramirez, Jordi
700	1		_aLee, Joohyung
700	1		_aFox, Susan H
700	1		_aMartin-Iverson, Mathew
700	1		_aNash, Joanne E
700	1		_aPiggott, Matthew J
700	1		_aBrotchie, Jonathan M
773	0		_tFASEB journal : official publication of the Federation of American Societies for Experimental Biology _gvol. 26 _gno. 5 _gp. 2154-63
856	4	0	_uhttps://doi.org/10.1096/fj.11-195016 _zAvailable from publisher's website
999			_c21555591 _d21555591